Oxidative stress has been postulated to play important roles in the pathogene sis of various diseases such as atherosclerosis in hyperlipidemic subjects. Although the pos sible role of oxidation of low-density lipoprotein (LDL) in the etiology of atherosclerosis has been studied extensively, the turnover of endogenous antioxidants, which is an important protection system against oxidative stress, remains to be elucidated. The aim of our study was to determine the change of the turnover of endogenous antioxidants such as glu tathione and ascorbic acid in case of hyperlipidemia, using Japanese white rabbits (JW) and Watanabe heritable hyperlipidemic rabbits (WHHL). The levels of total glutathione and low molecular weight thiols in the liver, kidney, and other organs in both strains of rabbits were similar. However, a kinetic analysis using L-buthionine-(S,R)-sulfoximine revealed that the rate of glutathione turnover in the liver and kidney of WHHL was about 50% lower than that of JW Furthermore, intravenously administered ascorbic acid disappeared more slowly in WHHL than in JW These results indicate that the turnovers of both glutathione and ascorbic acid in WHHL are depressed in comparison with that in JW. These changes would be closely related to the increased oxidizability of lipids in the circulation of hyperlipidemic subjects.
Before and after intravenous administration of BSO (1 mmol/kg), glutathione levels (GSH+2GSSG) in liver and kidney were determined. The half-lives of glutathione were calculated from the semilogarithmic plots of the changes in its tissue levels after BSO treatment (n=4). from the circulation at slow phase was significantly longer in WHHL than in JW. Many factors regulate the clearance of AA from the circulation. Among these, a rapid uptake by organs and a metabolic change in or gans would be two of the important factors. The former mainly affects the rate of rapid phase clearance, and the latter mainly affects the rate of slow phase clearance.
Considering that the half-life of AA at slow phase was significantly longer in WHHL than in JW, AA metabo lism might also be depressed in WHHL. It is well known that vitamins having antioxidant activity cooperate with one another for protecting cells and tissues from oxidative stress. For example, AA interacts with toco pheroxyl radicals in cell membrane lipid/bilayers, thereby forming monodehydroascorbic acid (23, 24). Monodehydroascorbic acid undergoes spontaneous dis mutation to form dehydroascorbic acid. Monodehydro ascorbic acid and dehydroascorbic acid are reduced to AA at the expense of NAD(P)H and GSH, respectively (9) (10) (11) . This sequence of reactions plays an important role in protecting cell membranes from the hazardous chain reaction of free radicals. Therefore a decreased turnover of GSH in WHHL would metabolically corre late, at least in part, with the decreased turnover of AA. The mechanism by which the metabolisms of both GSH and AA were depressed in WHHL is not now clear. It has been generally accepted that the turnovers of GSH and related antioxidants are accelerated by in creasing the oxidative stress (25). A depressed antioxi dant system, however, is closely related to the increased lipid peroxidation and oxidative tissue injury.
The functions of liver and kidney of WHHL alter with time as the animals become severely atherosclerotic. Such changes could affect the metabolism and trans port of endogenous molecules including AA and GSH. The present experiments were carried out by using 5 -mo-old rabbits. Although WHHL showed a marked hy perlipidemia and mild atherosclerosis, no appreciable sign for hepato-renal injury was obtained. Therefore the depression of the turnovers of GSH and AA in WHHL would occur independently from the decrease in hepato-renal functions caused by atherosclerotic changes. An important point remains unexplained: whether decreased turnover of the antioxidants observed in WHHL is applicable to other general hyperlipidemic subjects. In other words, whether this change is caused by a unique genetic nature of WHHL or not. To the best of our knowledge, this is the first report to describe the change in turnover of antioxidants in hyperlipidemic subjects. Therefore it is now difficult to compare the phenomenon in WHHL with that in other hyperlipi demic animal models. We suppose, however, that the hyperlipidemic state itself could generally lead to the re duction of the turnovers of GSH and other related an tioxidants. There are many kinds of enzymes and func tional proteins that regulate the metabolism of antioxi dants such as glutathione peroxidase and glutathione -S-transferase for GSH. Although the exact mechanism is uncertain, it is possible that the hyperlipidemic state affects the activities of these proteins that regulate the antioxidant metabolism. Therefore precise molecular mechanisms for the depression of the turnover of these antioxidants in WHHL and the turnover of these antiox idants in other animal models should be studied further.
Because of the presence of oxidized LDL in atheroscle rotic lesions of the aorta (26), oxidative modification of LDL has been postulated to be an important factor for the progression of atherosclerosis in hyperlipidemic subjects (1, 2) . The increased oxidizability of LDL has also been reported in patients with hyperlipidemia (27, 28). The endogenous antioxidant system is a critical factor for determining the oxidation resistance of the body. Thus examining the dynamic aspect of natural antioxidants in patients with hyperlipidemia and/or atherosclerosis would also be important for the treat ment of this disease. 
